2008
DOI: 10.1111/j.1600-0501.2008.01520.x
|View full text |Cite
|
Sign up to set email alerts
|

Histologic and clinical evaluation for maxillary sinus augmentation using macroporous biphasic calcium phosphate in human

Abstract: These results show that MBCP can be used as a grafting material for sinus floor augmentation, whether combined with other bone graft materials or not, and lead to a predictable prognosis for dental implants in the posterior maxillary area where there is insufficient vertical height for fixture installation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
31
1
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(36 citation statements)
references
References 18 publications
2
31
1
2
Order By: Relevance
“…These finding differ from what has been presented as ideal bone regeneration processes, where according to advancement of osteogenesis (in bone regeneration induced by biomaterials), the matrix of fibrillar tissue regresses; formation of bone type I is completed by the third or fourth week, and begins the phase of progressive substitution toward type II bone, where osteoclasts and osteoblasts appear (Anitua & Andia, 2000). At the same time, it also differs with the results presented by other research (Galindo-Moreno et al; Suba et al;Friedmann et al;Gotz et al, 2008;Lee et al, 2008;Norton et al, 2003, who have found that bone genesis produces starting with osteoblasts.…”
Section: Discussioncontrasting
confidence: 56%
“…These finding differ from what has been presented as ideal bone regeneration processes, where according to advancement of osteogenesis (in bone regeneration induced by biomaterials), the matrix of fibrillar tissue regresses; formation of bone type I is completed by the third or fourth week, and begins the phase of progressive substitution toward type II bone, where osteoclasts and osteoblasts appear (Anitua & Andia, 2000). At the same time, it also differs with the results presented by other research (Galindo-Moreno et al; Suba et al;Friedmann et al;Gotz et al, 2008;Lee et al, 2008;Norton et al, 2003, who have found that bone genesis produces starting with osteoblasts.…”
Section: Discussioncontrasting
confidence: 56%
“…[17][18][19][20] BCP has been also used as a carrier for rhBMP-2 in the alveolar ridge defect 21 and spine fusion 22,23 models. Jung et al 24 evaluated rhBMP-2-loaded HA/TCP in the rabbit calvarial onlay model, and concluded that this might be an ideal carrier system for rhBMP-2.…”
Section: Introductionmentioning
confidence: 99%
“…2 Biosynthetic substitutes, such as b-tricalcium phosphate (b-TCP), hydroxyapatite (HA), and mixtures of HA/b-TCP (biphasic calcium phosphates; BCP) have been successfully used as a graft material, because of their good biocompatibility and chemical composition, which resembles the composition of the natural bone matrix. [3][4][5][6] An important issue to consider regarding graft material degradation and bone ingrowth is the pore size; large pore sizes ( ‡ 500 mm) promote neovascularization and favor mineralized bone ingrowth, 1000 mm for the BCP scaffolds. Nevertheless, despite these structural optimizations, the lack of osteogenic properties still results in a slower rate of new bone formation.…”
Section: Introductionmentioning
confidence: 99%